COPADM regimen may improve the efficacy of BL. COPADM combined with Rituximab enables BL patients with greater benefit. The prognosis is significantly worse in patients older than 40 years old than in those less than 40 years old.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2018) studied this question.